| 1 |
What is the primary function of AI in the medical imaging industry?
|
To improve diagnostic accuracy and patient outcomes |
|
The use of AI can increase the speed, quality, and value of work done by healthcare professionals. It can reduce the risks of human error in the medical field. |
Understanding the factors influencing acceptability of AI in medical imaging domains among healthcare professionals: A scoping review |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 2 |
Which of the following is a key benefit of AI in radiology noted in the article?
|
Acts as a second medical opinion |
|
AI can decrease the risk of misdiagnosis. The AI system uses diagnostic accuracy metrics and assesses heir impact on task efficiency and patient health outcomes. |
Understanding the factors influencing acceptability of AI in medical imaging domains among healthcare professionals: A scoping review |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 3 |
What does AI literacy refer to according to the article?
|
Understanding and knowledge of AI technology |
|
AI literacy means the understanding of AL Technology and how to use it in our lives. |
Understanding the factors influencing acceptability of AI in medical imaging domains among healthcare professionals: A scoping review |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 4 |
Which factor is NOT listed as influencing the acceptability of AI among healthcare professionals?
|
The color of the AI machines |
|
The color of the AL machines don't affect the acceptability of AI, as it is only human preference. |
Understanding the factors influencing acceptability of AI in medical imaging domains among healthcare professionals: A scoping review |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 5 |
What role does social influence play in AI acceptability in healthcare according to the article?
|
Affects healthcare professionals’ decisions to use AI |
|
It is mentioned that social influence can lead healthcare workers to perceive that their use of AI is expected. |
Understanding the factors influencing acceptability of AI in medical imaging domains among healthcare professionals: A scoping review |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 6 |
What is a perceived threat regarding AI usage in healthcare settings?
|
Concerns about replacing healthcare professionals |
|
Healthcare professionals perceive AI as threatening their professional role at an individual and industry level compared to being an empowering tool that enables them to be better healthcare professionals. |
Understanding the factors influencing acceptability of AI in medical imaging domains among healthcare professionals: A scoping review |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 7 |
According to the article, what is essential for increasing AI acceptability among medical professionals?
|
Designing human-centred AI systems |
|
It is a way in which the AI system doesn't threaten the medical professionals, and to ensure that it is used for assistance only. |
Understanding the factors influencing acceptability of AI in medical imaging domains among healthcare professionals: A scoping review |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 8 |
What does the 'system usage' category of AI acceptability factors include according to the article?
|
Factors like value proposition and integration with workflows |
|
Value Proposition and Workflows Integration are mentioned in the 'system usage' category. |
Understanding the factors influencing acceptability of AI in medical imaging domains among healthcare professionals: A scoping review |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 9 |
How does ethicality impact AI acceptability among healthcare professionals?
|
Affects views on AI based on compatibility with professional values |
|
It is mentioned in the article that how healthcare professionals view AI basing on their value system or that of the medical profession can affect the acceptability of AI among the profession. |
Understanding the factors influencing acceptability of AI in medical imaging domains among healthcare professionals: A scoping review |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 10 |
What methodological approach did the article emphasize for future AI acceptability studies?
|
Considering user experience and system integration deeply |
|
AI acceptability studies should consider its theoretical and practical perspective. This will be valuable in facilitating the integration of AI into existing healthcare systems and workflows. |
Understanding the factors influencing acceptability of AI in medical imaging domains among healthcare professionals: A scoping review |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 11 |
What is the primary objective of using human embryonic stem cells in treating Parkinson’s disease?
|
To replace lost dopamine neurons. |
|
Parkinson’s disease is a common neurodegenerative disorder, which affects the neurons in our body. Using human stem cells can replace the dopamine neurons lost in the disease. |
Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson’s disease, STEM-PD |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 12 |
Which animal was used to test the STEM-PD product for safety and efficacy?
|
Rats |
|
The STEM-PD was tested on a total of 134 nude rats. |
Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson’s disease, STEM-PD |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 13 |
What was the duration of the preclinical safety study in rats mentioned in the article?
|
9 months |
|
It was conducted for 39 weeks, which is about 9 months |
Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson’s disease, STEM-PD |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 14 |
What is the name of the clinical trial phase mentioned for STEM-PD?
|
Phase I/IIa |
|
It is stated in the article |
Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson’s disease, STEM-PD |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 15 |
How is the STEM-PD product manufactured?
|
Under GMP-compliant conditions |
|
The STEM‑PD product was manufactured under GMP and quality tested in vitro and in vivo to meet regulatory requirements |
Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson’s disease, STEM-PD |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 16 |
According to the article, what confirmed the safety of the STEM-PD product in rats?
|
There were no adverse effects or tumor formation. |
|
It was sure that the STEM-PD didn't cause tumor or any toxic effects. |
Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson’s disease, STEM-PD |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 17 |
What key finding was noted in the efficacy study of STEM-PD in rats?
|
Transplanted cells reversed motor deficits in rats. |
|
It is stated in the study. |
Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson’s disease, STEM-PD |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 18 |
What specific markers were used to assess the purity of the STEM-PD batch?
|
FOXA2 and OTX2 |
|
It was mentioned in the article that batch #3 showed a purity of 98.7% FOXA2+/OTX2+ cells |
Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson’s disease, STEM-PD |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 19 |
What role do growth factors like FGF8b and SHH play in the manufacturing process of STEM-PD?
|
They are used in cell patterning for specific neural fates. |
|
It was mentioned in the article |
Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson’s disease, STEM-PD |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 20 |
What was a key outcome measured in the preclinical trials for efficacy in rats?
|
Recovery of motor function |
|
It was mentioned in the article that the rats had motor function improvements |
Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson’s disease, STEM-PD |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|